UNICA IRIS Institutional Research Information System

DEMELIA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 108.838
NA - Nord America 6.982
AS - Asia 2.715
SA - Sud America 389
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 59
OC - Oceania 2
Totale 119.135
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 105.148
US - Stati Uniti d'America 6.874
NL - Olanda 1.876
CN - Cina 1.091
SG - Singapore 972
UA - Ucraina 546
DE - Germania 334
SE - Svezia 302
BR - Brasile 298
FI - Finlandia 225
VN - Vietnam 203
GB - Regno Unito 171
FR - Francia 133
HK - Hong Kong 91
BD - Bangladesh 79
CA - Canada 58
KR - Corea 51
IN - India 39
AR - Argentina 35
RU - Federazione Russa 34
ID - Indonesia 26
JP - Giappone 24
MX - Messico 22
PK - Pakistan 19
IQ - Iraq 18
EC - Ecuador 15
TR - Turchia 15
UZ - Uzbekistan 14
BE - Belgio 13
MA - Marocco 13
VE - Venezuela 12
PH - Filippine 11
ZA - Sudafrica 11
KE - Kenya 10
PL - Polonia 10
CO - Colombia 9
SA - Arabia Saudita 9
AT - Austria 8
ES - Italia 7
IL - Israele 7
MY - Malesia 7
CR - Costa Rica 6
EG - Egitto 6
JO - Giordania 5
OM - Oman 5
PE - Perù 5
PY - Paraguay 5
TN - Tunisia 5
DK - Danimarca 4
IE - Irlanda 4
JM - Giamaica 4
LB - Libano 4
MD - Moldavia 4
MU - Mauritius 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
EU - Europa 3
HN - Honduras 3
IR - Iran 3
NG - Nigeria 3
NP - Nepal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AU - Australia 2
BB - Barbados 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HR - Croazia 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
TH - Thailandia 2
BG - Bulgaria 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GY - Guiana 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MN - Mongolia 1
MQ - Martinica 1
NI - Nicaragua 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SD - Sudan 1
SI - Slovenia 1
Totale 118.987
Salva come PNG Salva come JPEG
Città #
Cagliari 103.681
Amsterdam 1.869
Uta 1.136
Ashburn 905
Fairfield 549
Singapore 482
Woodbridge 427
San Jose 406
Chandler 385
Houston 340
Ann Arbor 335
Jacksonville 288
Boardman 274
Dallas 252
Wilmington 248
Dearborn 222
Nyköping 220
Cambridge 216
Beijing 200
Seattle 195
Helsinki 131
Santa Clara 121
Los Angeles 111
New York 101
Council Bluffs 92
Hefei 90
Nanjing 87
Hong Kong 85
Lauterbourg 78
Shanghai 66
Boston 65
Ho Chi Minh City 64
São Paulo 57
Seoul 46
The Dalles 46
Buffalo 44
Milan 39
Hanoi 38
Nanchang 38
Guangzhou 35
San Diego 33
Shenyang 32
Munich 31
Toronto 29
Hebei 27
Jiaxing 27
Verona 27
Changsha 24
London 22
Tokyo 22
Orange 21
Chicago 20
Rome 18
Auburn Hills 16
Dong Ket 16
Mountain View 16
Redwood City 16
Brooklyn 15
Denver 15
Frankfurt am Main 15
Redondo Beach 15
Tianjin 15
Jinan 14
Norwalk 14
Orem 14
Tashkent 14
Brussels 13
San Francisco 13
Turku 13
Kunming 12
Manchester 12
Phoenix 12
Washington 12
Columbus 11
Ningbo 11
Mexico City 10
Atlanta 9
Da Nang 9
Jakarta 9
Zhengzhou 9
Ansbach 8
Brasília 8
Chennai 8
Porto Alegre 8
Sassari 8
Biên Hòa 7
Carrboro 7
Guayaquil 7
Nairobi 7
Turin 7
Wuhan 7
Düsseldorf 6
Lahore 6
Rio de Janeiro 6
Taizhou 6
Warsaw 6
Caxias do Sul 5
Dhaka 5
Erbil 5
Haiphong 5
Totale 114.879
Salva come PNG Salva come JPEG
Nome #
Proteomic investigation of whole saliva in Wilson's disease 4.345
null 3.544
Bipolar disorders and Wilson's disease 3.290
The burden of depressive and bipolar disorders in celiac disease 2.945
Coeliac disease and psychiatric comorbidity: epidemiology, pathophysiological mechanisms, quality-of-life, and gluten-free diet effects 2.767
Value of histochemical stains for copper in the diagnosis of Wilson's disease 2.755
Late onset Wilson's disease 2.605
Premature vascular deterioration in young patients affected by Wilson's disease: a pilot study 2.579
Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? 2.453
Homogeneous magnetic resonance imaging of brain abnormalities in bipolar spectrum disorders comorbid with Wilson's disease 2.427
alpha 2 Antiplasmin and disseminated intravascular coagulation in liver cirrhosis 2.402
Mutation analysis of the ATP7B gene in a new group of Wilson's disease patients: Contribution to diagnosis. 2.366
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 2.356
Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena 2.309
A Top-Down proteomic study of the whole saliva of subjects affected by Wilson disease reveals qualitative and quantitative alterations of the S100A8 and S100A9 proteins 2.283
Psychiatric comorbidity in Wilson’s disease 2.271
Potential biomarker discover of the Wilson’s disease by top-down proteomic investigation of whole saliva 2.133
Quality of life and psychiatric symptoms in wilson's disease: The relevance of bipolar disorders 2.072
Histologic evolution and long-term outcome of Wilson's disease: results of a single-center experience 1.947
The relationship between copper and steatosis in Wilson's disease 1.859
TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses 1.859
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B 'e' antigen-negative chronic hepatitis B genotype D 1.838
Fine structure of hepatic sinusoids in Wilson’s disease. A scanning electron microscopic study 1.793
Non-invasive assessment of silent liver fibrosis in patients with systemic sclerosis 1.784
A randomized controlled trial of sequential pegylated interferon-alpha and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B 1.778
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 1.747
Reversibility of fibrosis in Wilson disease 1.720
null 1.710
Uneven hepatic copper distribution in Wilson's disease 1.631
Kayser-Fleischer ring in Wilson's disease: a cohort study 1.562
Non-invasive assessment of hepatic fibrosis in a series of patients with Wilson's Disease 1.533
Brain MR spectroscopy in the evaluation of Wilson's disease: Correlation with clinical status and response to therapy 1.512
Secondary RBD in a patient affected by chronic hepatic encephalopathy: a case report. 1.486
HBV and HCV infections in Wilson's disease patients: Copper overload could be protective? 1.478
null 1.366
Dynamic 99mTc-HIDA hepatobiliary scintigraphy in vanishing bile duct syndrome 1.351
Animal models are reliably mimicking human diseases? A morphological study that compares animal with human NAFLD 1.308
Usefulness of dynamic hepatobiliary scintigraphy in Wilson's disease 1.261
Peginterferon-alpha-2a plus adefovir vs. peginterferon alpha-2a for 48 weeks in hbeag-negative chronic hepatitis B: Preliminary 24-week results of the peg for B randomized multicenter trial 1.242
Wilson’s disease with late onset 1.222
Patterns of chronic hepatitis B in Central Italy: a cross-sectional study. 1.146
Massive haemosiderosis in Wilson’s disease 1.048
Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis 1.022
HFE gene mutations and Wilson's disease in Sardinia 1.015
Tolerability of Peg interferon-alpha 2b and Ribavirin therapy in patients with chronic hepatitis C and glucose-6-phosphate dehydrogenase deficiency 1.006
Resolved Psychosis after Liver Transplantation in a Patient with Wilson's Disease 1.006
Syncitial giant cell hepatitis. A case report 1.004
[Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy]. FT Effetto a breve termine della terapia con DL-carnitina per os ed L-carnitina e.v. nei pazienti uremici cronici in trattamento emodialitico. 994
A randomized controlled trial of pegylated interferon-alpha 2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B 973
Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study 964
Massive haemosiderosis in Wilson's disease - Reply 963
SEQUENTIAL PEGINTERFERON ALPHA-2A AND TELBIVUDINE OR VICE VERSA FOR HBEAG-NEGATIVE CHRONIC HEPATITIS B: PRELIMINARY END-OF-TREATMENT RESULTS OF THE TEL-B-PEG RANDOMIZED TRIAL 961
HFE gene mutations and Wilson's disease in Sardinia 960
Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy 959
Brain MRI and SPECT in the diagnosis of early neurological involvement in Wilson's disease 932
Massive hepatic haemosiderosis in Wilson's disease 857
Clinical features of Wilson's disease in Sardinia 853
Interferon beta-1a alone or in combination with ribavirin: A randomized trial to compare efficacy and safety in chronic hepatitis C 846
A randomized controlled trial of amantadine plus interferon-alpha 2a vs. interferon-alpha 2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-alpha 2a monotherapy 846
Dosage of the hepatic copper in the normal range in a patient affected by Wilson’s disease. 802
Wilson’s disease with late onset 764
Syncitial giant cell hepatitis: a new form of chronic liver disease 725
Ductular reaction and oval cell prolipheration in chronic hepatitis C. 700
Unusual evolution from overt autoimmune hypothyroidism to hyperthyroidism after IFN-α therapy for chronic hepatitis. 700
Peginterferon alpha-2a (40kD) monotherapy vs peginterferon alpha-2a and ribavirin in naive patients with chronic hepatitis C: Preliminary results of the SMIEC II trial in patients with early viral clearance on peginterferon monotherapy 693
Enhanced response to peginterferon-alpha-2a-based triple therapy in previously non-responsive chronic hepatitis C: Final results of pretty study RID E-8970-2010 675
Chronic viral hepatitis in Hiv + drug addicts 653
Comparison of MRI, EEG, EPs and ECD-SPECT in Wilson's disease 643
Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902-1983) 625
Computerized cranial tomography in presymptomatic and hepatic form of Wilson's disease 616
Final results of the SMIEC trial in natve patients with hepatitis C: Double therapy (peginterferonalfa2a+ribavirin) vs peginterferon monotherapy in early viral responders and vs triple therapy (peginterferon plus ribavirin plus amantadine) in early non responders 608
Wilson's disease maps between the D13S169 and D13S173 loci 598
[Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis]. FT La precallicreina plasmatica (fattore Fletcher) nella cirrosi epatica. 590
HCV transmission in family members of subjects with HCV related chronic liver disease 545
Diagnostic value of 24 hr urinary copper excretion after penicillamine challenge in the adult Wilson's disease patients. 544
Predictive testing for Wilson's disease using tightly linked and flanking DNA markers 539
Coagulazione, fibrinolisi e shunt porto-sistemico nelle epatopatie croniche 532
null 520
A randomized controlled trial of amantadine plus interferon alpha-2a vs interferon-alpha-2a in naive patients with chronic hepatitis C randomized based on early response to interferon alpha-2a alone. 515
IS INTRAPULMONARY SHUNT IN CIRRHOTIC-PATIENTS CORRELATED WITH PORTACAVAL-SHUNT 500
HDL-cholesterol in chronic uremia during hemodialytic treatment 481
Idiopathic adulthood ductopenia presenting with chronic recurrent cholestasis. A case report 471
Pseudo-porphyria cutanea tarda in patients hemodialyzed for chronic renal insufficiency. Clinical, metabolic and immunological aspect 452
Usefulness and limitations of determination of lactate dehydrogenase enzymes in the diagnosis of liver diseases 430
Transient elastography in patients with chronic autoimmune hepatitis: is a goog tool in evaluation of hepatic fibrosis? 411
The role of a double liver needle biopsy in the diagnosis of Wilson's disease. 407
Hypothalamo-pituitary-adrenal function in liver cirrhosis of viral etilogy 383
Efficacy of lamivudine in patients with antiHBe plus chronic active hepatitis B. 376
Diagnostic value of histochemical stains for copper in Wilson's disease 371
Efficacy and safety of long-term IFN therapy in active chronic hepatitis D: Six years of sustained response to the treatment. Case report. 366
ABNORMAL PULMONARY EPITHELIAL PERMEABILITY IN LIVER-CIRRHOSIS 359
Serum ALT level, phlebotomy treatment and alpha-interferon therapy in chronic hepatitis C. 297
Totale 119.135
Salva come PNG Salva come JPEG
Categoria #
all - tutte 156.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.247 0 0 0 0 513 825 601 319 419 514 902 1.154
2022/20238.388 993 1.192 1.086 737 831 914 320 665 385 416 485 364
2023/20247.300 491 421 320 788 762 1.091 953 480 343 536 588 527
2024/20259.186 2.045 2.139 1.148 944 599 643 817 93 211 156 184 207
2025/20266.367 242 280 581 508 302 277 618 433 2.152 461 325 188
2026/20271.300 90 173 409 623 5 0 0 0 0 0 0 0
Totale 119.135